Cornelis Verhoef Selected Research

Cornelis Verhoef Research Topics

Disease

91	Neoplasm Metastasis (Metastasis) 04/2024 - 06/2004
80	Neoplasms (Cancer) 04/2024 - 04/2006
36	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 10/2010
22	Rectal Neoplasms (Rectal Cancer) 05/2024 - 05/2005
20	Melanoma (Melanoma, Malignant) 12/2023 - 03/2011
17	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 04/2006
12	Breast Neoplasms (Breast Cancer) 01/2023 - 04/2014
7	Margins of Excision 01/2024 - 05/2012
7	Aggressive Fibromatosis (Desmoid) 01/2022 - 01/2016
6	Necrosis 01/2023 - 01/2009
6	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 11/2003
5	Fibroma (Fibromatosis) 01/2022 - 01/2019
4	Hemorrhage 05/2024 - 04/2015
4	Peritoneal Neoplasms 02/2023 - 01/2019
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2022 - 07/2008
3	Peritoneal Diseases 01/2024 - 02/2023
3	Lymphatic Metastasis 08/2023 - 01/2016
3	Mesothelioma 01/2023 - 01/2019
3	Colonic Neoplasms (Colon Cancer) 04/2022 - 01/2015
3	Carcinoma (Carcinomatosis) 03/2022 - 05/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2023 - 08/2023
2	Infections 01/2023 - 12/2019
2	Sarcopenia 10/2022 - 01/2022
2	Pseudomyxoma Peritonei 09/2022 - 01/2019
2	Liposarcoma 01/2020 - 07/2014
2	Disease Progression 01/2019 - 09/2013
2	Uveal melanoma 12/2016 - 01/2016
2	Liver Neoplasms (Liver Cancer) 12/2015 - 06/2015
2	Fibrosis (Cirrhosis) 04/2013 - 01/2010
1	Hypotension (Low Blood Pressure) 05/2024
1	Epilepsy (Aura) 05/2024
1	Nausea 05/2024
1	Morbid Obesity 05/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2024

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
13	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 04/2006
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 04/2006
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 12/2012
5	Bevacizumab (Avastin)FDA Link 01/2024 - 12/2012
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 11/2003
5	CateninsIBA 01/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2016
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 12/2019
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
4	MicroRNAs (MicroRNA)IBA 10/2020 - 07/2014
4	LigandsIBA 01/2020 - 01/2013
4	Imatinib Mesylate (Gleevec)FDA Link 09/2013 - 07/2008
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023 - 01/2013
3	GlucocorticoidsIBA 01/2023 - 01/2013
3	Carcinoembryonic AntigenIBA 01/2023 - 01/2016
3	Indicators and Reagents (Reagents)IBA 10/2022 - 09/2019
3	CollagenIBA 01/2020 - 01/2013
3	Peptides (Polypeptides)IBA 01/2020 - 01/2013
3	CytokinesIBA 01/2018 - 01/2013
2	Neurofibromin 2 (Merlin)IBA 04/2024 - 12/2023
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 03/2022
2	AsbestosIBA 12/2022 - 01/2019
2	Codon (Codons)IBA 04/2022 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 12/2021
2	talimogene laherparepvecIBA 01/2022 - 12/2021
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 11/2017
2	Cell-Free Nucleic AcidsIBA 10/2021 - 12/2016
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2012
2	pazopanib FDA Link 01/2019 - 01/2015
1	vinyltriethoxysilane (VTES)IBA 05/2024
1	AnticoagulantsIBA 05/2024
1	Tranexamic Acid (AMCA)FDA Link 05/2024
1	Protein Kinase InhibitorsIBA 04/2024
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2024
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2024

Therapy/Procedure

52	Therapeutics 04/2024 - 12/2007
35	Drug Therapy (Chemotherapy) 04/2024 - 12/2007
23	Radiotherapy 12/2023 - 05/2005
18	Neoadjuvant Therapy 01/2024 - 03/2011
16	Hyperthermic Intraperitoneal Chemotherapy 04/2024 - 01/2019
14	Cytoreduction Surgical Procedures 04/2024 - 01/2019
11	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 12/2008
6	Infusion Pumps (Infusion Pump) 04/2024 - 12/2019
6	Chemoradiotherapy 01/2024 - 01/2009
5	Mastectomy (Mammectomy) 01/2023 - 05/2014
5	Hepatectomy 04/2022 - 05/2009
5	Radiofrequency Ablation 01/2022 - 09/2009
4	Aftercare (After-Treatment) 02/2024 - 06/2012
4	Adjuvant Radiotherapy 12/2023 - 02/2011
4	Palliative Care (Palliative Therapy) 10/2023 - 01/2015
4	Immunotherapy 01/2023 - 12/2016
4	Surgical Amputation (Amputations) 03/2022 - 12/2007
4	Segmental Mastectomy (Lumpectomy) 12/2021 - 02/2015
3	Pelvic Exenteration 05/2024 - 10/2007
3	Length of Stay 05/2024 - 12/2022
3	Proctectomy 01/2023 - 11/2005
3	Ligation 01/2023 - 12/2015
2	Prophylactic Mastectomy 01/2023 - 08/2016
2	Decompression 07/2021 - 06/2021
2	Breast Implants (Breast Implant) 08/2018 - 08/2016
2	Operative Surgical Procedures 04/2015 - 01/2011
2	Adjuvant Chemotherapy 03/2015 - 01/2015
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 05/2024
1	Medical Day Care (Partial Hospitalization) 05/2024
1	Bariatric Surgery 05/2024